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known as the ‘temporal gradient’.
Explanation of this phenomenon
remains a mystery although some
have suggested that it reflects the
time-course of consolidation. The
fact that temporal gradients can
extend back 20 years makes this a
difficult explanation to accept.
The roles of different structures
Limbic and frontal structures are
best thought of as mediating
declarative memory but what role do
these different structures play in the
process of memory? The
hippocampus is divided into four
‘fields’ and one of these, CA1,
receives inputs from all parts of the
prefrontal cortex. Moreover, neurons
in CA1 have a very high degree of
interconnectivity. Memory for an
event is thought to represent the
integration of different aspects of
information and, although there is no
direct proof, it is thought that CA1
provides the anatomical basis and
that other parts of the hippocampal
formation ‘fix’ a particular event and
then mediate storage of that event in
the temporal cortex.
Far less is known about the
function of diencephalic structures in
memory but one idea is that these
are involved in encoding information
which enables the time-based
characteristics of a memory to be
established. The frontal lobes are
generally thought to be involved in
more ‘strategic’ aspects of memory.
These strategic processes involve the
operations used to determine what
aspects of an event are encoded and
those that control how memories are
retrieved. Thus, studies of patients
with frontal lesions have shown that
their free recall of information is
often poor but improves dramatically
with prompting. Also their learning
processes often reveal a failure to
attend to the most relevant aspects of
an event. There is also evidence that
the pre-frontal cortex is crucial for
determining the truth of memories
because, quite often in frontal lobe
damage, patients suffer from ‘illusory
memory’ or ‘confabulation’ in which
they tend to remember things that
have not actually happened.
It should be obvious that the
study of human memory is complex,
not least because the problems can
be approached on two
fundamentally different levels —
the biological and the psychological.
There is progress in both these
domains but it will be a long time
before they come together to
provide a single explanation of
human memory.
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Autosomal dominant polycystic
kidney disease (ADPKD) is a
common inherited disorder
(incidence of 1 in 1,000), the cardinal
manifestations of which are renal and
liver cysts and intracranial aneurysm.
The gene defective in the most
common and severest form of
ADPKD, PKD1, is broadly expressed
and encodes a 4,302 amino acid
plasma-membrane protein,
polycystin-1 (PKD1) [1–3]. Despite
detailed knowledge of the domain
architecture for the majority of the
PKD1 sequence (Figure 1), little is
known of PKD1 function.
Identification of PKD1 mutations has
been hampered by the presence of
numerous PKD1 homologues
elsewhere on chromosome 16 [2] and
in vitro expression of full-length
PKD1 is yet to be reported.
Here, we report the identification
of three previously unrecognised
domains in PKD1 that are likely to
possess distinct carbohydrate-, lipid-
and protein-binding functions. These
domains were identified using PSI-
BLAST database searches [4,5] with
an expect-value (E-value) inclusion
threshold of E < 0.01. Independent
evidence was provided using a
generalised profile analysis method
[6], in which the significances of
findings were better than p < 0.01 in
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In functional neuroimaging, a range of
different techniques are used to indicate
which parts of the brain are receiving
most blood flow and are, hence, most
active. Normal people are given memory
tasks while undergoing functional
neuroimaging. Such studies have
confirmed much of what was already
known about the neuroanatomical basis
of memory but the evidence has also
thrown up some new issues and
addressed some controversies.
First, neuroimaging studies have
indicated different patterns of activation
when people are answering questions
about episodic and semantic memory —
contradicting the evidence from
amnesia. Studies have also highlighted
the role of the frontal lobes of the brain
in encoding and retrieval, although the
original view that the left frontal region
mediated encoding and the right
mediated retrieval is now in some doubt.
A more robust finding is the
demonstration of frontal lobe involvement
in the setting up of new links between
objects (known as ‘association’) and the
hippocampal involvement in detecting
that an object is novel (‘stimulus novelty’).
Most interesting, perhaps, has been the
discovery that a little-known parietal lobe
structure, the right precuneus, is active
during retrieval — a finding that is
stimulating various ideas about how
the various elements of a memory might
be brought together during the process
of retrieval.
Functional neuroimaging
all cases. An extracellular region lying
between the leucine-rich repeats
(LRRs) and the amino-terminal PKD
domain was found to contain a WSC
domain that is also present in tandem
in a fungal β-1,3-exoglucanase [7] and
in Saccharomyces cerevisiae cell-wall
integrity and stress-response
component proteins [8]. An
intracellular region between the first
two transmembrane regions of PKD1
was found to contain a β-barrel LH2
domain homologous to a non-catalytic
domain of lipoxygenases [9]. This
domain has been proposed to
facilitate binding of lipase and
lipoxygenase substrates to the
enzymes’ active sites [9]. This
indicates that the PKD1 LH2 domain
is likely to possess a lipid-binding
function. Multiple alignments and
information relating to these domains
may be found in the Supplementary
material, and are available from the
SMART database [10,11].
The third novel domain of PKD1
was found to be a member of a family
that was recently identified in
G-protein-coupled receptors (GPCRs)
including the Ca2+-independent
α-latrotoxin receptor (latrophilin or
CL-1) and in other membrane-
associated proteins such as the sea
urchin receptor for egg jelly protein,
REJ [12,13]. A PSI-BLAST search
with the sequence of this domain
from REJ (residues 1,353–1,401)
demonstrates significant similarity
with PKD1 (residues 3,002–3,050)
within one iteration using an E-value
threshold of 0.01 (Figure 2).
Latrophilin/CL-1 is known to be
cleaved within this domain [14], so it
has been termed the GPCR
proteolytic site (GPS) domain [15].
GPS domains in human, Fugu and
Caenorhabditis elegans PKD1 proteins
contain only one of the two putative
disulphide bridges found in CL-1;
the second disulphide bridge appears
to be missing in GPS domains of
C. elegans proteins F31D5.4 and
F31D5.5 (Figure 2). Others have
pointed out that CL-1 and three
other GPS-domain-containing
proteins, CL-2, CL-3 and CD97, are
all proteolytically processed
endogenously [14,16] and that the
amino acids surrounding the putative
cleavage site are highly conserved
among GPS domain sequences
[12,15]. The cleavage site in the
CL-1 GPS domain is highly
conserved in PKD1 orthologues: rat
CL-1 is cleaved at the Leu–Thr
peptide bond of the sequence
His836-Leu-Thr-Asn839 [14], which
corresponds to His3047-Leu-Thr-
Ala3050 in human PKD1.
Consequently, we predict that PKD1
is endogenously cleaved to produce
an amino-terminal chain of
3,048 amino acids and a
carboxy-terminal chain of
1,255 amino acids. By analogy, the
PKD1 amino-terminal chain is
unlikely to be released after cleavage,
as the two subunits of cleaved rat
CL-1 have unexpectedly been shown
to be strongly associated [14].
The exogenous ligand for CL-1,
α-latrotoxin, requires both the GPS
domain and the hormone receptor
domain of CL-1 (the latter is also in
secretin receptors) for binding [12].
Unfortunately, the endogenous
ligand of CL-1 remains unknown.
Given that homologous molecules
often bind homologous receptors,
however, the as-yet-unknown ligands
for PKD1 and CL-1 may yet prove to
be homologues. It may be significant
that a single base-pair change
resulting in substitution of Val3008
with Leu, just amino-terminal to the
GPS domain, has been observed in a
patient with ADPKD, although it is
unproven whether this mutation
causes ADPKD [17]. 
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Figure 1
A schematic representation of the domain
architectures of PKD1, human PKDREJ, sea
urchin REJ and human CL-1 (not to scale).
Domain positions are taken, in part, from
reference [18]. The large amino-terminal
extracellular region of PKD1 has been
recognised to contain several domain types.
An extended region (the REJ domain) before
the first putative transmembrane sequence is
similar to part of REJ [19] and PKDREJ [22]; a
report that this region contains four fibronectin
type 3 domains is not substantiated by
detailed sequence analysis [19]. PKD1 is
proposed to contain 11 transmembrane (TM)
regions; the carboxy-terminal six of these are
contained in a region homologous to the
product of a second ADPKD gene, PKD2,
and pore-forming α-subunits of Ca2+ and Na+
channels [18,23]. By contrast to REJ, which
contains only a single TM sequence [19],
human PKDREJ also contains 11 predicted
TM regions [21]). A predicted coiled-coil
structure at the PKD1 carboxyl terminus is
involved in its interaction with PKD2 [24]. The
GPS, WSC and lipoxygenase homology
2 domains are described in the text and
Supplementary material.
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PKD1, CL-1 and REJ possess
functional similarities that are likely
to be due to their common GPS
domains and transmembrane regions.
Each of these molecules is suggested
to mediate transmembrane influx of
Ca2+ [13,18,19]. However, this
function of PKD1 has been ascribed
to its carboxy-terminal PKD2-like
and voltage-gated Ca2+ channel-like
region [17], which is lacking in CL-1
and REJ. It is notable that REJ,
which contains a single
transmembrane region, and a CL-1
truncation variant containing only its
GPS-domain-containing extracellular
region and the single amino-terminal
transmembrane region, both support
Ca2+ influx [13,20]. Consequently,
we predict that the PKD1
transmembrane region 1 functions
similarly in supporting Ca2+ influx.
In conclusion, the three
previously unrecognised WSC, GPS
and LH2 domains in human PKD1
are tentatively suggested to bind
three different ligand types, namely
carbohydrate, protein and lipid,
respectively. Most of the amino-
terminal region (amino acids 1–3,466)
of human PKD1 has now been
assigned domain homologues.
However, mice heterozygous for a
PKD1 mutation that results in a
protein that lacks its carboxy-terminal
region (amino acids 3,497–4,293) and
yet retains all the newly identified
domains have been shown to possess
kidney and pancreas defects [21].
This demonstrates that further
experiments are required to
determine the functions of different
regions and domains of this large and
complex molecule.
Supplementary material
Supplementary material including multiple
alignments and descriptions of the three
domains is available at http://current-
biology.com/supmat/supmatin.htm.
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Figure 2
Multiple alignment of GPS domains
containing the suggested cleavage site
(marked by an arrow). Amino acid residues
are coloured according to a 80% consensus
(calculated using the program Consensus
[25]: + indicates positively charged residues
(H, K and R, green); – indicates negatively
charged residues (D and E, green); a
indicates aromatic residues (F, H, W and Y,
highlighted in yellow); b indicates big
residues (E, F, I, K, L, M, Q, R, W and Y, grey
or yellow); c indicates charged residues (D,
E, H, K and R, green); h indicates
hydrophobic residues (A, C, F, H, I, L, M, V,
W and Y, highlighted in yellow); l indicates
aliphatic residues (I, L and V, highlighted in
yellow); o indicates alcohol residues (S and
T, pink), p indicates polar residues (D, E, H,
K, N, Q, R, S and T, dark blue); s indicates
small residues (A, C, S, T, D, N, V, G and P,
light blue); u indicates tiny residues (A, G
and S, light blue). Residues that are
predicted to form disulphide bridges are
shown as white-on-black. Predicted [26]
secondary structures are indicated below the
alignment (e/E, extended or β-strand
structure; h/H, helix); lowercase letters
represent predictions that have expected
accuracies of > 72% and uppercase letters
represent predictions that have expected
accuracies of > 82%. Residue numbers and
GenBank identifiers are shown following the
alignment. Abbreviations: Ce, Caenorhabditis
elegans; Fr, Fugu rubripes; Hs, Homo
sapiens; Mm, Mus musculus; Rn, Rattus
norvegicus; Spu, Strongylocentrotus
purpuratus; MEGF2, multiple EGF domain-
containing protein 2; EMR1, EGF domain-
containing mucin-like hormone receptor 1;
CIRL, calcium-independent receptor of
alpha-latrotoxin (latrophilin); BAI1, brain-
specific angiogenesis inhibitor 1.
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The PLAT domain: a
new piece in the PKD1
puzzle
Alex Bateman* and
Richard Sandford†
Autosomal dominant polycystic
kidney disease (ADPKD) has a
prevalence of 1 in 800 of the world’s
population and accounts for 10% of
individuals who require renal
replacement therapy, either dialysis
or transplantation. Renal cyst
formation occurs as part of a ‘two-
hit’ process in which inactivation of
both alleles of ADPKD genes leads
to abnormalities of cell proliferation,
apoptosis and differentiation [1]. Of
ADPKD cases, 85% are due to
mutations in the PKD1 gene, which
encodes a 4,302 amino acid protein,
polycystin-1 (PKD1), of unknown
function. Comparison of the PKD1
sequence with homologous
sequences from mouse and Fugu
predicts polycystin-1 to have a large
extracellular region of 3,000 amino
acid residues, a region containing
11 putative transmembrane
segments and a short intracellular
tail [2]. A well-defined extracellular
domain structure is apparent; the
presence of amino-terminal leucine-
rich repeats, a C-type-lectin domain
and multiple PKD repeats suggests a
role in cell–cell or cell–matrix
interactions (Figure 1) [3]. So far, no
extracellular ligands of polycystin-1
have been identified. Of the
intracellular regions of PKD1,
functional properties have been
defined only for the short 198 amino
acid carboxy-terminal region, which
contains a predicted coiled-coil
domain. These include a direct
interaction with the carboxyl
terminus of the protein encoded by
PKD2, polycystin-2 [4], activation of
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Figure 1
Schematic diagram of the domain
organisation of PLAT domain proteins.
Information and alignments for each of the
domains can be found in the Pfam database
[14,15] using the following identifiers or
accession numbers: leucine-rich repeats,
PF00560; C-type lectin, PF00059; LDL-A,
PF00057; PKD domains, PF00801; PLAT
domain, PF01477; lipoxygenase, PF00305;
Zn2+-dependent phospholipase C,
PF00882; lipase, PF00151. Abbreviation:
aa, amino acids.
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